famotidine has been researched along with Diabetic Glomerulosclerosis in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wakabayashi, N | 1 |
| Takeda, S | 1 |
| Imai, T | 1 |
| Akimoto, T | 1 |
| Nagata, D | 1 |
1 other study available for famotidine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Unexpected observation of glomerular crescents in a patient with diabetes who developed drug-induced acute tubulointerstitial nephritis: A possible feature of diabetic nephropathy?
Topics: Acute Kidney Injury; Aged; Biopsy; Diabetic Nephropathies; Famotidine; Glomerulonephritis; Histamine | 2015 |